Adrafinil‐induced orofacial dyskinesia
Identifieur interne : 003A41 ( Istex/Corpus ); précédent : 003A40; suivant : 003A42Adrafinil‐induced orofacial dyskinesia
Auteurs : Stéphane Thobois ; Jing Xie ; Helena Mollion ; Isabelle Benatru ; Emmanuel BroussolleSource :
- Movement Disorders [ 0885-3185 ] ; 2004-08.
English descriptors
- KwdEn :
Abstract
We describe the first case of orofacial abnormal movements induced by adrafinil, a vigilance promoting agent of the same pharmacological class as modafinil. The dyskinesias did not spontaneously recover despite adrafinil withdrawal for a 4‐month period. They were secondly dramatically improved by tetrabenazine, a presynaptic dopaminergic depleting drug which was introduced after the 4‐month adrafinil‐free period. © 2004 Movement Disorder Society
Url:
DOI: 10.1002/mds.20154
Links to Exploration step
ISTEX:2A9C289DE8CE06EB4B0DC30057317B7DE96F5CB5Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Adrafinil‐induced orofacial dyskinesia</title><author><name sortKey="Thobois, Stephane" sort="Thobois, Stephane" uniqKey="Thobois S" first="Stéphane" last="Thobois">Stéphane Thobois</name><affiliation><mods:affiliation>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</mods:affiliation></affiliation></author><author><name sortKey="Xie, Jing" sort="Xie, Jing" uniqKey="Xie J" first="Jing" last="Xie">Jing Xie</name><affiliation><mods:affiliation>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</mods:affiliation></affiliation></author><author><name sortKey="Mollion, Helena" sort="Mollion, Helena" uniqKey="Mollion H" first="Helena" last="Mollion">Helena Mollion</name><affiliation><mods:affiliation>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</mods:affiliation></affiliation></author><author><name sortKey="Benatru, Isabelle" sort="Benatru, Isabelle" uniqKey="Benatru I" first="Isabelle" last="Benatru">Isabelle Benatru</name><affiliation><mods:affiliation>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</mods:affiliation></affiliation></author><author><name sortKey="Broussolle, Emmanuel" sort="Broussolle, Emmanuel" uniqKey="Broussolle E" first="Emmanuel" last="Broussolle">Emmanuel Broussolle</name><affiliation><mods:affiliation>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:2A9C289DE8CE06EB4B0DC30057317B7DE96F5CB5</idno><date when="2004" year="2004">2004</date><idno type="doi">10.1002/mds.20154</idno><idno type="url">https://api.istex.fr/document/2A9C289DE8CE06EB4B0DC30057317B7DE96F5CB5/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003A41</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Adrafinil‐induced orofacial dyskinesia</title><author><name sortKey="Thobois, Stephane" sort="Thobois, Stephane" uniqKey="Thobois S" first="Stéphane" last="Thobois">Stéphane Thobois</name><affiliation><mods:affiliation>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</mods:affiliation></affiliation></author><author><name sortKey="Xie, Jing" sort="Xie, Jing" uniqKey="Xie J" first="Jing" last="Xie">Jing Xie</name><affiliation><mods:affiliation>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</mods:affiliation></affiliation></author><author><name sortKey="Mollion, Helena" sort="Mollion, Helena" uniqKey="Mollion H" first="Helena" last="Mollion">Helena Mollion</name><affiliation><mods:affiliation>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</mods:affiliation></affiliation></author><author><name sortKey="Benatru, Isabelle" sort="Benatru, Isabelle" uniqKey="Benatru I" first="Isabelle" last="Benatru">Isabelle Benatru</name><affiliation><mods:affiliation>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</mods:affiliation></affiliation></author><author><name sortKey="Broussolle, Emmanuel" sort="Broussolle, Emmanuel" uniqKey="Broussolle E" first="Emmanuel" last="Broussolle">Emmanuel Broussolle</name><affiliation><mods:affiliation>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2004-08">2004-08</date><biblScope unit="vol">19</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="965">965</biblScope><biblScope unit="page" to="966">966</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">2A9C289DE8CE06EB4B0DC30057317B7DE96F5CB5</idno><idno type="DOI">10.1002/mds.20154</idno><idno type="ArticleID">MDS20154</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>adrafinil</term><term>orofacial dyskinesias</term><term>tetrabenazine</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We describe the first case of orofacial abnormal movements induced by adrafinil, a vigilance promoting agent of the same pharmacological class as modafinil. The dyskinesias did not spontaneously recover despite adrafinil withdrawal for a 4‐month period. They were secondly dramatically improved by tetrabenazine, a presynaptic dopaminergic depleting drug which was introduced after the 4‐month adrafinil‐free period. © 2004 Movement Disorder Society</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Stéphane Thobois MD, PhD</name><affiliations><json:string>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</json:string></affiliations></json:item><json:item><name>Jing Xie MD, PhD</name><affiliations><json:string>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</json:string></affiliations></json:item><json:item><name>Helena Mollion MD</name><affiliations><json:string>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</json:string></affiliations></json:item><json:item><name>Isabelle Benatru MD</name><affiliations><json:string>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</json:string></affiliations></json:item><json:item><name>Emmanuel Broussolle MD, PhD</name><affiliations><json:string>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>orofacial dyskinesias</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>adrafinil</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>tetrabenazine</value></json:item></subject><language><json:string>eng</json:string></language><abstract>We describe the first case of orofacial abnormal movements induced by adrafinil, a vigilance promoting agent of the same pharmacological class as modafinil. The dyskinesias did not spontaneously recover despite adrafinil withdrawal for a 4‐month period. They were secondly dramatically improved by tetrabenazine, a presynaptic dopaminergic depleting drug which was introduced after the 4‐month adrafinil‐free period. © 2004 Movement Disorder Society</abstract><qualityIndicators><score>2.211</score><pdfVersion>1.3</pdfVersion><pdfPageSize>612 x 810 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>449</abstractCharCount><pdfWordCount>1479</pdfWordCount><pdfCharCount>10407</pdfCharCount><pdfPageCount>2</pdfPageCount><abstractWordCount>61</abstractWordCount></qualityIndicators><title>Adrafinil‐induced orofacial dyskinesia</title><genre><json:string>Serial article</json:string></genre><host><volume>19</volume><pages><total>2</total><last>966</last><first>965</first></pages><issn><json:string>0885-3185</json:string></issn><issue>8</issue><subject><json:item><value>Clinical/Scientific Note with Video</value></json:item></subject><genre></genre><language><json:string>unknown</json:string></language><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>2004</publicationDate><copyrightDate>2004</copyrightDate><doi><json:string>10.1002/mds.20154</json:string></doi><id>2A9C289DE8CE06EB4B0DC30057317B7DE96F5CB5</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/2A9C289DE8CE06EB4B0DC30057317B7DE96F5CB5/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/2A9C289DE8CE06EB4B0DC30057317B7DE96F5CB5/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/2A9C289DE8CE06EB4B0DC30057317B7DE96F5CB5/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Adrafinil‐induced orofacial dyskinesia</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>Wiley Subscription Services, Inc., A Wiley Company</p></availability><date>2004</date></publicationStmt><notesStmt><note type="content">*A videotape accompanies this article.</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Adrafinil‐induced orofacial dyskinesia</title><author><persName><forename type="first">Stéphane</forename><surname>Thobois</surname><roleName type="degree">MD, PhD</roleName></persName><note type="correspondence"><p>Correspondence: Hôpital Neurologique Pierre Wertheimer, Service de Neurologie D (Prof. G. Chazot), 59 Blvd. Pinel, 69003 Lyon, France</p></note><affiliation>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</affiliation></author><author><persName><forename type="first">Jing</forename><surname>Xie</surname><roleName type="degree">MD, PhD</roleName></persName><affiliation>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</affiliation></author><author><persName><forename type="first">Helena</forename><surname>Mollion</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</affiliation></author><author><persName><forename type="first">Isabelle</forename><surname>Benatru</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</affiliation></author><author><persName><forename type="first">Emmanuel</forename><surname>Broussolle</surname><roleName type="degree">MD, PhD</roleName></persName><affiliation>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2004-08"></date><biblScope unit="vol">19</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="965">965</biblScope><biblScope unit="page" to="966">966</biblScope></imprint></monogr><idno type="istex">2A9C289DE8CE06EB4B0DC30057317B7DE96F5CB5</idno><idno type="DOI">10.1002/mds.20154</idno><idno type="ArticleID">MDS20154</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2004</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>We describe the first case of orofacial abnormal movements induced by adrafinil, a vigilance promoting agent of the same pharmacological class as modafinil. The dyskinesias did not spontaneously recover despite adrafinil withdrawal for a 4‐month period. They were secondly dramatically improved by tetrabenazine, a presynaptic dopaminergic depleting drug which was introduced after the 4‐month adrafinil‐free period. © 2004 Movement Disorder Society</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>orofacial dyskinesias</term></item><item><term>adrafinil</term></item><item><term>tetrabenazine</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>Article category</head><item><term>Clinical/Scientific Note with Video</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2003-10-15">Received</change><change when="2003-12-12">Registration</change><change when="2004-08">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/2A9C289DE8CE06EB4B0DC30057317B7DE96F5CB5/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="subtitle">Official Journal of the Movement Disorder Society</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="80"><doi origin="wiley" registered="yes">10.1002/mds.v19:8</doi><numberingGroup><numbering type="journalVolume" number="19">19</numbering><numbering type="journalIssue">8</numbering></numberingGroup><coverDate startDate="2004-08">August 2004</coverDate></publicationMeta><publicationMeta level="unit" type="shortCommunication" position="150" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.20154</doi><idGroup><id type="unit" value="MDS20154"></id></idGroup><countGroup><count type="pageTotal" number="2"></count></countGroup><titleGroup><title type="articleCategory">Clinical/Scientific Note with Video</title><title type="tocHeading1">Clinical/Scientific Notes</title></titleGroup><copyright ownership="thirdParty">Copyright © 2004 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="2003-10-15"></event><event type="manuscriptAccepted" date="2003-12-12"></event><event type="publishedOnlineEarlyUnpaginated" date="2004-04-05"></event><event type="firstOnline" date="2004-04-05"></event><event type="publishedOnlineFinalForm" date="2004-08-03"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:FullText result:FullText" date="2010-03-09"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">965</numbering><numbering type="pageLast">966</numbering></numberingGroup><correspondenceTo>Hôpital Neurologique Pierre Wertheimer, Service de Neurologie D (Prof. G. Chazot), 59 Blvd. Pinel, 69003 Lyon, France</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS20154.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="0"></count><count type="referenceTotal" number="14"></count><count type="wordTotal" number="1258"></count></countGroup><titleGroup><title type="main" xml:lang="en">Adrafinil‐induced orofacial dyskinesia <link href="#fn1"></link></title><title type="short" xml:lang="en">Clinical/Scientific Notes</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Stéphane</givenNames><familyName>Thobois</familyName><degrees>MD, PhD</degrees></personName><contactDetails><email normalForm="stephane.thobois@chu-lyon.fr">stephane.thobois@chu‐lyon.fr</email></contactDetails></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Jing</givenNames><familyName>Xie</familyName><degrees>MD, PhD</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Helena</givenNames><familyName>Mollion</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Isabelle</givenNames><familyName>Benatru</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au5" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Emmanuel</givenNames><familyName>Broussolle</familyName><degrees>MD, PhD</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="FR" type="organization"><unparsedAffiliation>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">orofacial dyskinesias</keyword><keyword xml:id="kwd2">adrafinil</keyword><keyword xml:id="kwd3">tetrabenazine</keyword></keywordGroup><supportingInformation><p> This article includes Supplementary Video Clips, available online at <url href="http://www.interscience.wiley.com/jpages/0885-3185/suppmat"> http://www.interscience.wiley.com/jpages/0885‐3185/suppmat. </url></p><supportingInfoItem><mediaResource alt="supporting information" href="urn-x:wiley:08853185:media:mds20154:suppmat_965"></mediaResource><caption>Supporting Information file suppmat_965.mpg</caption></supportingInfoItem></supportingInformation><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>We describe the first case of orofacial abnormal movements induced by adrafinil, a vigilance promoting agent of the same pharmacological class as modafinil. The dyskinesias did not spontaneously recover despite adrafinil withdrawal for a 4‐month period. They were secondly dramatically improved by tetrabenazine, a presynaptic dopaminergic depleting drug which was introduced after the 4‐month adrafinil‐free period. © 2004 Movement Disorder Society</p></abstract></abstractGroup></contentMeta><noteGroup><note xml:id="fn1"><p>A videotape accompanies this article.</p></note></noteGroup></header></component></istex:document></istex:metadataXml><!--Version 0.6 générée le 3-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Adrafinil‐induced orofacial dyskinesia</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Clinical/Scientific Notes</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Adrafinil‐induced orofacial dyskinesia</title></titleInfo><name type="personal"><namePart type="given">Stéphane</namePart><namePart type="family">Thobois</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</affiliation><description>Correspondence: Hôpital Neurologique Pierre Wertheimer, Service de Neurologie D (Prof. G. Chazot), 59 Blvd. Pinel, 69003 Lyon, France</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Jing</namePart><namePart type="family">Xie</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Helena</namePart><namePart type="family">Mollion</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Isabelle</namePart><namePart type="family">Benatru</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Emmanuel</namePart><namePart type="family">Broussolle</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Neurology, The Pierre Wertheimer Neurological Hospital, Lyon, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre authority="originalCategForm">shortCommunication</genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2004-08</dateIssued><dateCaptured encoding="w3cdtf">2003-10-15</dateCaptured><dateValid encoding="w3cdtf">2003-12-12</dateValid><copyrightDate encoding="w3cdtf">2004</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="references">14</extent><extent unit="words">1258</extent></physicalDescription><abstract lang="en">We describe the first case of orofacial abnormal movements induced by adrafinil, a vigilance promoting agent of the same pharmacological class as modafinil. The dyskinesias did not spontaneously recover despite adrafinil withdrawal for a 4‐month period. They were secondly dramatically improved by tetrabenazine, a presynaptic dopaminergic depleting drug which was introduced after the 4‐month adrafinil‐free period. © 2004 Movement Disorder Society</abstract><note type="content">*A videotape accompanies this article.</note><subject lang="en"><genre>Keywords</genre><topic>orofacial dyskinesias</topic><topic>adrafinil</topic><topic>tetrabenazine</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title><subTitle>Official Journal of the Movement Disorder Society</subTitle></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><note type="content"> This article includes Supplementary Video Clips, available online at http://www.interscience.wiley.com/jpages/0885‐3185/suppmat.Supporting Info Item: Supporting Information file suppmat_965.mpg - </note><subject><genre>article category</genre><topic>Clinical/Scientific Note with Video</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><detail type="issue"><caption>no.</caption><number>8</number></detail><extent unit="pages"><start>965</start><end>966</end><total>2</total></extent></part></relatedItem><identifier type="istex">2A9C289DE8CE06EB4B0DC30057317B7DE96F5CB5</identifier><identifier type="DOI">10.1002/mds.20154</identifier><identifier type="ArticleID">MDS20154</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2004 Movement Disorder Society</accessCondition><recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003A41 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 003A41 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:2A9C289DE8CE06EB4B0DC30057317B7DE96F5CB5
|texte= Adrafinil‐induced orofacial dyskinesia
}}
| This area was generated with Dilib version V0.6.23. |  |